I agree that this site is using cookies. You can find further informations here.
X
Arnán Sangerman, Montserrat
18  results:
Search for persons X
?
1

Practical tips for managing FLT3 mutated acute myeloid leuk..:

Arnán Sangerman, Montserrat ; Fernández Moreno, Ainhoa ; García Quintana, Antonio...
Expert Review of Hematology.  15 (2022)  3 - p. 203-214 , 2022
Link: https://doi.org/10.1080/..
 
?
2

A sex-informed approach to improve the personalised decisio..:

Maggioni, Giulia ; Bersanelli, Matteo ; Travaglino, Erica...
The Lancet Haematology.  10 (2023)  2 - p. e117-e128 , 2023
Link: https://doi.org/10.1016/..
 
?
3

AML-122 Midostaurin Maintenance versus Allo SCT versus W&W ..:

de la Fuente, Adolfo ; Beya, Marina Diaz ; Beneit, Paola...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S215 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Poster: AML-122 Midostaurin Maintenance versus Allo SCT ver..:

de la Fuente, Adolfo ; Beya, Marina Diaz ; Beneit, Paola...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S129 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Randomized phase 2 trial of pevonedistat plus azacitidine v..:

Sekeres, Mikkael A. ; Watts, Justin ; Radinoff, Atanas...
Leukemia.  35 (2021)  7 - p. 2119-2124 , 2021
Link: https://doi.org/10.1038/..
 
?
6

Correction to: Randomized phase 2 trial of pevonedistat plu..:

Sekeres, Mikkael A. ; Watts, Justin ; Radinoff, Atanas...
Leukemia.  35 (2021)  12 - p. 3637-3637 , 2021
Link: https://doi.org/10.1038/..
 
?
7

MDS-336: Phase 2 Study of Pevonedistat + Azacitidine versus..:

Watts, Justin ; Adès, Lionel ; Radinoff, Atanas...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S323-S324 , 2020
Link: https://doi.org/10.1016/..
 
?
8

A sex-informed approach to improve the personalised decisio..:

Maggioni, Giulia ; Bersanelli, Matteo ; Travaglino, Erica...
Reproducció del document publicat a: https://doi.org/10.1016/S2352-3026(22)00323-4.  , 2023
Link: http://hdl.handle.net/24..
 
?
9

A sex-informed approach to improve the personalised decisio..:

Maggioni, Giulia ; Bersanelli, Matteo ; Travaglino, Erica...
Reproducció del document publicat a: https://doi.org/10.1016/S2352-3026(22)00323-4.  , 2023
Link: http://hdl.handle.net/24..
 
?
10

Randomized phase 2 trial of pevonedistat plus azacitidine v..:

Sekeres, Mikkael A ; Watts, Justin ; Radinoff, Atanas...
boreal:242702.  , 2021
Link: http://hdl.handle.net/20..
 
?
11

Randomized phase 2 trial of pevonedistat plus azacitidine v..:

Sekeres, Mikkael A ; Watts, Justin ; Radinoff, Atanas...
boreal:242702.  , 2021
Link: http://hdl.handle.net/20..
 
?
12

Correction to: Randomized phase 2 trial of pevonedistat plu..:

Sekeres, Mikkael A ; Watts, Justin ; Radinoff, Atanas...
boreal:254643.  , 2021
Link: http://hdl.handle.net/20..
 
?
13

Correction to: Randomized phase 2 trial of pevonedistat plu..:

Sekeres, Mikkael A ; Watts, Justin ; Radinoff, Atanas...
boreal:254643.  , 2021
Link: http://hdl.handle.net/20..
 
?
14

P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTAT..:

De La Fuente, A. ; Diaz Beya, M. ; Beneit, P....
HemaSphere.  6 (2022)  - p. 422-423 , 2022
Link: https://doi.org/10.1097/..
 
?
15

P568: REAL-LIFE EXPERIENCE OF TREATMENT REFRACTORY/RELAPSED..:

Pomares Marin, H. ; Villarreal Hernández, J. ; Condom Esteve, M....
HemaSphere.  6 (2022)  - p. 467-468 , 2022
Link: https://doi.org/10.1097/..
 
1-15